Hope Bancorp Inc.

5 days ago · globenewswire.com

– Late-Breaking Data to Include HOPE-3 Delayed-Start and Natural History Analyses Submitted in the Recent Major Amendment to the Deramiocel BLA – – PDUFA Target Action Date of November 22, 2026 – SAN DIEGO, Sept. 17, 2026 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced that data from HOPE-3 and its open-label extension (OLE) of Deramiocel, the Company's lead asset for the treatment of Duchenne muscular dystrophy (DMD), will be presented in a late-breaking poster and an oral presentation at the 31 st Annual Congress of the World Muscle Society (WMS 2026), taking place September 29 – October 3, 2026, in Hiroshima, Japan.

2 months ago · globenewswire.com

--Independent Peer Review Provides External Validation of the Trial's Design, Statistical Methodology and Findings-- --Randomized, Double-Blind, Placebo-Controlled HOPE-3 Phase 3 Trial (n=106) Met Primary Endpoint, with Deramiocel Slowing Upper Limb Function Decline by 54 Percent versus Placebo (PUL 2.0, p=0.03) and Showing Clinically Meaningful Cardiac Benefit--

2 months ago · businesswire.com

NEW YORK--(BUSINESS WIRE)--Bank of Hope, subsidiary of Hope Bancorp, Inc. (NASDAQ: HOPE), is expanding the ways it connects with customers and community members through a creative branding campaign centered on a sponsorship of 'BTS THE CITY ARIRANG NEW YORK'. Celebrating ‘BTS THE CITY ARIRANG NEW YORK' as people from around the world gather in New York City, this campaign serves as a unique activation targeted at today's consumers who seek meaningful relationships with the brands with which the.

2 months ago · seekingalpha.com

Hope Bancorp, Inc. (HOPE) Q2 2026 Earnings Call Transcript

2 months ago · zacks.com

While the top- and bottom-line numbers for Hope Bancorp (HOPE) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

2 months ago · zacks.com

Hope Bancorp (HOPE) came out with quarterly earnings of $0.27 per share, beating the Zacks Consensus Estimate of $0.26 per share. This compares to earnings of $0.19 per share a year ago.

2 months ago · prnewswire.com

CHICAGO, July 20, 2026 /PRNewswire/ -- Old Republic International Corporation (NYSE: ORI) – today announced a national partnership with Hope For The Warriors® (HOPE), a nonprofit organization dedicated to supporting veterans, service members, military families, and caregivers. The partnership reflects a shared commitment to strengthening communities by supporting those who have served our country and the families who serve alongside them.

3 months ago · prnewswire.com

LONDON, ON, June 29, 2026 /PRNewswire/ - VersaBank (TSX: VBNK) (Nasdaq: VBNK) today announced it made a $60,000 donation to The Salvation Army's Harvest Hope Campaign and presented a cheque to The Salvation Army executives in front of approximately 700 people at VersaBank's Summer Celebration event in London, Ontario on Saturday, June 27, 2026. "This economy is proving difficult for many people and I've always felt that it's important to help people out in a time of need," said David Taylor, Founder and President, VersaBank.

3 months ago · globenewswire.com

SAN DIEGO, June 26, 2026 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for rare diseases, today announced positive five-year data from its ongoing HOPE-2 Open-Label Extension (OLE) study of Deramiocel, the Company's lead cell therapy candidate for Duchenne Muscular Dystrophy (DMD). The data will be presented at the Parent Project Muscular Dystrophy (PPMD) 2026 Annual Conference, taking place June 25-27, 2026, in Orlando, Florida, alongside previously reported results from the Company's HOPE-3 Phase 3 trial.

4 months ago · seekingalpha.com

Hope Bancorp, Inc. (HOPE) Shareholder/Analyst Call Prepared Remarks Transcript